tiprankstipranks
Trevi Therapeutics Inc (TRVI)
NASDAQ:TRVI
US Market

Trevi Therapeutics (TRVI) Financial Statements

Compare
455 Followers

Trevi Therapeutics Financial Overview

Trevi Therapeutics's market cap is currently $581.06M. The company's EPS TTM is $-0.47; its P/E ratio is ―; Trevi Therapeutics is scheduled to report earnings on March 19, 2025, and the estimated EPS forecast is $-0.12. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ -123.00K$ -43.00K$ -50.00K$ -47.00K
Operating Income$ -51.52M$ -33.92M$ -29.91M$ -32.48M$ -32.49M
EBITDA$ -51.52M$ -33.80M$ -29.86M$ -32.43M$ -32.44M
Net Income$ -47.91M$ -29.07M$ -29.15M$ -33.94M$ -32.76M
Balance Sheet
Cash & Short-Term Investments$ 107.62M$ 82.97M$ 12.59M$ 36.83M$ 45.00M
Total Assets$ 110.90M$ 89.40M$ 123.02M$ 38.48M$ 47.13M
Total Debt$ 1.03M$ 1.34M$ 9.18M$ 14.63M$ 14.21M
Net Debt$ -33.06M$ -31.06M$ -3.41M$ -22.20M$ -30.79M
Total Liabilities$ 11.26M$ 6.86M$ 15.56M$ 21.40M$ 19.85M
Stockholders' Equity$ 99.64M$ 82.55M$ 107.46M$ 17.07M$ 27.28M
Cash Flow
Free Cash Flow$ -38.29M$ -31.85M$ -28.33M$ -28.95M$ -29.03M
Operating Cash Flow$ -38.26M$ -31.71M$ -28.18M$ -28.95M$ -29.00M
Investing Cash Flow$ -21.53M$ 59.43M$ -107.37M$ 0.00$ -32.00K
Financing Cash Flow$ 61.48M$ -7.91M$ 111.31M$ 20.77M$ 16.72M
Currency in USD

Trevi Therapeutics Earnings and Revenue History

Trevi Therapeutics Debt to Assets

Trevi Therapeutics Cash Flow

Trevi Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis